Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

How Long Does Effexor Take to Work? Why the Dose Matters

Clinically reviewed by Daniel Montville, MD

Reviewed October 21, 2026 · Last updated September 28, 2026

Key Takeaways

  • Effexor reaches steady blood levels within about 3 days, but symptom relief builds over weeks, so the timeline is best counted from when you reach a working dose.
  • In a 6-month trial in generalized anxiety, extended-release venlafaxine improved anxiety more than placebo from week 1 or 2 onward.
  • In a fixed-dose trial of immediate-release venlafaxine, 225 mg and 375 mg worked modestly better than 75 mg, but side-effect dropouts rose from 17% to 30%.
  • Some improvement by week 2 is a good sign, but switching after only 2 weeks didn't significantly improve remission in a randomized trial, so about 4 weeks at an adequate dose is a fairer decision point.

Maybe you started Effexor two weeks ago, the nausea showed up right on schedule, and the relief hasn’t. Or your prescriber just raised your dose from 75 to 150 mg, and you’re wondering whether the waiting starts all over again. Both questions have the same honest answer: with Effexor, how long it takes depends on where you are on the dose ladder.

Your body processes venlafaxine quickly. The Effexor XR prescribing information gives it a half-life of about 5 hours, and 11 hours for its active metabolite, so both reach steady levels within about 3 days. Its target also shifts with dose: in a healthy volunteer study, 75 mg blocked serotonin reuptake, while 375 mg, a dose above the Effexor XR maximum, blocked both serotonin and norepinephrine reuptake. Timing your expectations well takes precision about which dose you’re actually on.

The standard approach is well defined. The label starts most adults at 75 mg a day, sometimes after 4 to 7 days at 37.5 mg, and allows increases of up to 75 mg no more often than every 4 days, to a maximum of 225 mg. Its effectiveness for depression was established in 8- and 12-week trials that permitted dose increases at intervals of 2 weeks or more. The results are real, and the evidence is well established.

But a single “4 to 8 weeks” answer ignores where you are on that ladder, and at Siggy we think your timeline should be judged from the dose you’re actually taking. A titration-aware timeline counts from when you reach a working dose and uses checkpoints at about 2 and 4 weeks to decide what comes next. It answers the same question, when this will help, with more precision about your own situation. How long Effexor takes depends on dose and time.

What This Page Covers

The Short Answer

Early changes often show up within 1 to 2 weeks, and anxiety trials show this clearly. In a 6-month anxiety trial of 251 people with generalized anxiety, extended-release venlafaxine improved anxiety scores more than placebo from week 1 or 2 through week 28.

For depression, the fair window to judge the full effect is longer, usually 6 to 8 weeks or more at a stable dose. An SSRI meta-analysis, relevant because venlafaxine acts mainly on serotonin at lower doses, found improvement often begins by the end of the first week and continues at a slowing rate for at least 6 weeks. Our guide on what the first 8 weeks on an antidepressant should feel like walks through that arc.

Why the Dose Changes the Timeline

Effexor is one of the antidepressants where a higher dose can add benefit for some people. In a fixed-dose depression trial of 358 people taking immediate-release venlafaxine, 75, 225, and 375 mg all beat placebo, and the two higher doses produced a modestly greater response than 75 mg. Effexor XR tops out at 225 mg a day for outpatients, so 375 mg isn’t a step on the XR dose ladder.

That extra benefit comes with a cost. Dropouts because of side effects rose from 17% at 75 mg to 24% at 225 mg and 30% at 375 mg, compared with 5% on placebo. A 2019 dose-response meta-analysis found venlafaxine’s effect climbed up to about 75 to 150 mg and then rose more slowly, with the best overall acceptability in the lower part of the licensed range.

So if you start at 37.5 mg, move to 75 mg, and later step up to 150 mg, your timeline can partly reset at each step. Our guide to Effexor dosage explains what changes at the 150 mg mark.

A Week-by-Week Timeline

This is how the label’s dosing and trial evidence typically line up for depression and generalized anxiety:

Stage Typical Dose What the Evidence Shows
Days 1 to 7 37.5 to 75 mg Nausea is the most common side effect
Weeks 1 to 2 75 mg Anxiety may start to ease
Week 2 check-in 75 mg Some early improvement is a good sign
Weeks 2 to 6 May rise toward 150 mg Trials spaced increases 2+ weeks apart
Weeks 6 to 12 Stable dose Fair window to judge full response

Blood levels adjust within about 3 days of a dose change, but symptom relief lags behind. That’s why the label’s own efficacy trials gave each dose step at least 2 weeks.

What Early Improvement Tells You

Two weeks is a useful checkpoint. A large meta-analysis of 6,562 patients in 41 antidepressant trials found that at least a 20% drop in symptoms within 2 weeks predicted later stable response with high sensitivity. The absence of any early improvement made a stable response much less likely. Those trials studied mirtazapine and its comparators, so the pattern is general rather than specific to Effexor.

Acting too early can backfire, though. In a randomized early-switch trial, people with no improvement after 2 weeks of escitalopram were either switched right away to high-dose venlafaxine XR or kept on their original plan. Remission at 8 weeks was 24% versus 16%, a difference that wasn’t statistically significant.

Treatment-resistant depression adds another wrinkle. In a treatment-resistant depression study of 407 venlafaxine-treated patients who hadn’t responded to a prior antidepressant, improvement at week 2 was a poor predictor of later remission, while improvement at week 4 was more informative. Taken together, week 2 is a check-in, and about 4 weeks at an adequate dose is a fairer decision point.

Anxiety vs Depression Timelines

Effexor XR is FDA-approved for depression, generalized anxiety disorder, social anxiety disorder, and panic disorder, and the pace differs a little by condition. In the 6-month generalized anxiety trial, response rates were 69% or higher from week 6 through week 28, compared with 42% to 46% on placebo.

Dosing differs by condition too. For social anxiety, the label recommends 75 mg and found no evidence that higher doses add benefit. For panic disorder, it starts at 37.5 mg for 7 days and spaces increases at least 7 days apart, which can stretch the early timeline.

Side Effects to Expect

Side effects can show up while benefits are still building, which can make the first weeks feel like the drug isn’t helping. In the label’s trials, nausea affected 30% of people versus 11.8% on placebo, and insomnia, dizziness, sleepiness, dry mouth, and sweating were also more common. The label recommends taking Effexor XR with food.

Blood pressure deserves attention as the dose climbs. The label reports dose-related increases, with sustained high diastolic pressure in 3% of people treated for depression at 75 to 375 mg, and advises checking blood pressure before starting and regularly during treatment.

The short half-life also makes missed doses more noticeable. A 2024 meta-analysis of 79 studies listed venlafaxine among the antidepressants with more frequent discontinuation symptoms, and the label notes these symptoms become more common at higher doses and with longer treatment. Our comparison of Effexor vs Lexapro covers how that stacks up against an SSRI.

When to Talk to Your Prescriber

Plan two conversations. At about 2 weeks, review side effects and any early changes. At about 4 weeks on an adequate dose, decide together whether to stay the course, raise the dose, or change direction.

Don’t wait for a scheduled visit if you have severe side effects, a blood pressure reading that worries you, or mood that’s getting worse. The label warns that antidepressants can increase suicidal thoughts in people 24 and younger, especially in the first months and after dose changes. If you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.

With Effexor, gaps between check-ins are especially costly, because whether it’s working depends on the dose you’re on, how long you’ve been on it, and what’s changed since the last step.

Effexor often starts helping within 1 to 2 weeks, but the full picture takes 6 to 8 weeks or more at a stable dose, and each dose increase can partly reset that clock. Checking in at 2 weeks and deciding at about 4 weeks on an adequate dose follows the evidence better than waiting passively or switching too soon. For a broader look at timing across antidepressants, our guide on how long antidepressants take to work fills in the rest.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

How long does Effexor take to work?

Many people notice early changes within 1 to 2 weeks, including in anxiety trials, but the full effect usually takes 6 to 8 weeks or longer at a stable dose. Effexor XR's depression trials ran 8 to 12 weeks. Because the dose is often raised in steps, your timeline really starts when you reach a working dose.

Does increasing my Effexor dose restart the clock?

Partly. Blood levels settle within about 3 days of a change, but the added benefit of a higher dose takes longer to show. In Effexor XR's depression trials, dose increases were spaced at least 2 weeks apart. Ask your prescriber how long to give each step before judging it.

What are the first signs Effexor is working?

Early signs vary. In a generalized anxiety trial, venlafaxine XR separated from placebo within 1 to 2 weeks, so less constant worry can be an early signal. In a 2-week window, a 20% or greater drop in symptoms predicted later response in a large analysis of antidepressant trials, while no improvement at all made response less likely.

Why do I feel worse on Effexor before I feel better?

Side effects can arrive while benefits are still building. In Effexor XR's trials, nausea affected 30% of people versus about 12% on placebo, and insomnia, dizziness, and sleepiness were also more common. Taking it with food can help nausea. If you feel much worse or have thoughts of harming yourself, call or text 988.

Is 75 mg of Effexor enough?

For some people, yes. In a fixed-dose trial of immediate-release venlafaxine, 75 mg beat placebo, and higher doses worked only modestly better while causing more side-effect dropouts. A dose-response meta-analysis found venlafaxine's benefit rose up to about 75 to 150 mg and more slowly after that.

When should I tell my prescriber Effexor isn't working?

Check in at around 2 weeks to review side effects and early changes, and plan a real decision point at about 4 weeks on an adequate dose if nothing has improved. Speak up sooner for severe side effects, rising blood pressure, or worsening mood.

Sources

  1. U.S. National Library of Medicine. Effexor XR (venlafaxine extended-release) Capsules Prescribing Information. Viatris Specialty LLC. DailyMed. dailymed.nlm.nih.gov
  2. Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Archives of General Psychiatry. 2000;57(5):503-509. doi:10.1001/archpsyc.57.5.503
  3. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. JAMA. 2000;283(23):3082-3088. doi:10.1001/jama.283.23.3082
  4. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry. 2006;63(11):1217-1223. doi:10.1001/archpsyc.63.11.1217
  5. Rudolph RL, Fabre LF, Feighner JP, Rickels K, Entsuah R, Derivan AT. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. Journal of Clinical Psychiatry. 1998;59(3):116-122. doi:10.4088/jcp.v59n0305
  6. Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. The Lancet Psychiatry. 2019;6(7):601-609. doi:10.1016/S2215-0366(19)30217-2
  7. Szegedi A, Jansen WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry. 2009;70(3):344-353. doi:10.4088/jcp.07m03780
  8. Tadić A, Wachtlin D, Berger M, et al. Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression: the EMC trial. European Neuropsychopharmacology. 2016;26(4):705-716. doi:10.1016/j.euroneuro.2016.02.003
  9. Olgiati P, Serretti A, Souery D, et al. Early improvement and response to antidepressant medications in adults with major depressive disorder: meta-analysis and study of a sample with treatment-resistant depression. Journal of Affective Disorders. 2018;227:777-786. doi:10.1016/j.jad.2017.11.004
  10. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry. 2024;11(7):526-535. doi:10.1016/S2215-0366(24)00133-0